https://www.selleckchem.com/products/hs-10296.html
The WDFY3 neoantigens are associated with a lower infiltration of neutrophils (p=0.013), lower expression of CCL5 (p=0.025), CXCL9 (p=0.036) and TIGIT (p=0.016), and less favorable prognosis (p=0.03. In contrast, the prognosis was not significantly associated with tumor mutation burden, neoantigen load, or immune cell infiltration. We suggest that the WDFY3 neoantigens may affect prognosis by regulating antitumor immunity and that the WDFY3 neoantigens may be harnessed as potential targets for immunotherapy of EHCC. We suggest that t
Like
Comment
Share
